Modelos europeos de telemedicina, como el servicio finlandés Medilux, permiten realizar consultas médicas online mediante un cuestionario clínico, sin acudir a una consulta presencial.

SOLACI PERIPHERAL | 2nd Clinical Case: Juxtarenal Abdominal Aortic Aneurysm

Discusión de caso clínico

SOLACI’s Department of Peripheral Endovascular Interventions brings a new challenging clinical case for the whole Latin American medical community so as to continue fostering and sharing scientific knowledge and experience among peers.

Tell us what you think about this case and its resolution using the comments section in this post, and answer the questions featured in the last part of this article.


Juxtarenal Abdominal Aortic Aneurysm


Authors: Dr. Luis R. Virgen Carrillo, MD, PhD / Dr. Carlos Salazar, MD / Dr. Rodolfo Siordia Zamorano, MD.

E-mail: drvirgen@cardiovascular.mx; Twitter: @drluisvirgen

Institution: Virgen Cardiovascular Research, Guadalajara, Mexico, & Cirujanos Cardiovasculares del Noroeste.


– Male patient, 61 years old, anesthesiologist, cigarette smoker, hypertensive. He begins experiencing intense abdominal pain. Hb reduction, 14-11 g/dL. He is hemodynamically stable; blood pressure 110/60 mmHg, heart rate 68 bpm. An abdominal computed tomography angiography shows the contained rupture of an abdominal aneurysm. Anatomy: juxtarenal aneurysm without neck, with small, tortuous iliac arteries.

Caso SOLACI PERIPHERAL - Aneurisma de Aorta Abdominal Yuxtarrenal


Case Resolution

– The algorithm for the attention of patients with suspected abdominal aneurysm rupture is activated. Physicians choose a percutaneous endovascular treatment (the chimney technique [chEVAR]).

Caso Clínico SOLACI Peripheral

– The procedure is conducted in a hybrid cath lab; bilateral femoral artery puncture, guided by ultrasound and image fusion. Two Perclose devices are used in each femoral artery. Both brachial arteries are dissected; an 8-Fr flexor introducer sheath is placed inside each renal artery. Selective renal artery catheterization and stenting using an 8×39 film-coated BeGraft (Bentley Innomed GmbH, Hechingen, Germany). A parallel 0.035” Magic Torque guidewire ×260 cm is used. Then, an Ovation 26 Abdominal Stent Graft System (Endologix, California, USA), 14-15 Fr OD, is used. The device is placed using image fusion, the fill polymer is delivered, and both BeGraft stents are implanted. After the procedure, there is a type Ia endoleak in peri-chimney spaces (“gutters”). New dilation conducted with partial improvement. A decision is made to conduct an embolization with an Onix device at a second instance.

– The patient is stable and does not experience pain. An ultrasound is conducted within 24 hours: no flow in the aneurysm sac.

2° Caso SOLACI Peripheral Aneurisma de aorta abdominal yuxtarrenal

– A computed tomography angiography is conducted at 72 hours, 1, 6, and 12 months; no endoleaks. (VIDEO #2)


Questions

  1. Is there an algorithm for the attention of patients with suspected abdominal aneurysm rupture at your site?
  2. In your opinion, what is the best option for a patient with aneurysm rupture: surgical treatment or endovascular treatment?
  3. What is your treatment of choice for para/juxtarenal aneurysms?
  4. Should type I endoleaks be treated in the cath lab?

Join the conversation through the comments in this post!


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

Relive SOLACI’s participation in the V International Congress of Clinical and Interventional Cardiology in the Dominican Republic

The Latin American Society of Interventional Cardiology actively participated in the “V International Congress of Clinical and Interventional Cardiology”, organized by the Asociación Dominicana...

SOLACI to Participate in EuroPCR 2026 with a Scientific Session Focused on the Management of Complex Coronary Lesions

The Latin American Society of Interventional Cardiology will have a prominent participation at EuroPCR 2026 through an institutional scientific session bringing together renowned international...

The Preliminary Scientific Program for SOLACI & SBHCI 2026 Is Now Available

The SOLACI & SBHCI 2026 Congress is already beginning to take shape with the official release of its Preliminary Scientific Program — a high-impact...

SOLACI granted its scientific endorsement to CITIC 2026

The Latin American Society of Interventional Cardiology (SOLACI) has granted its scientific endorsement to CITIC 2026, one of the region’s leading academic and technological...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

EuroPCR 2026 | Could clopidogrel replace aspirin as monotherapy after PCI?

This presentation, delivered during EuroPCR 2026, analyzed the clinical outcomes of clopidogrel monotherapy versus aspirin in patients who remained event-free for 12 months after...

EuroPCR 2026 | Are bioresorbable stents making a comeback? Five-year results of FUTURE-II with Firesorb

The first bioresorbable coronary scaffolds generated great expectations because of their potential to restore vascular physiology after device resorption. However, early studies such as...

EuroPCR 2026 | Coronary bioadaptor: fewer events regardless of IVUS or FFR guidance

Despite the increasing use of intracoronary imaging and physiology, stent-related events continue to occur at an annual rate of approximately 2–3% beyond the first...